Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) went up by 1.71% during the previous trading session, and it is maintaining the win ahead of Monday’s trading session. The share price of the Biotechnology giant went up by $152.43 to trade ended Monday trading at $149.87. This is up from the $149.87 price recorded on Thursday’s trading session. Thanks to this latest performance, ALNY is closer to the higher price 52-week target of $202.00 and further from the lowest price target of $74.00. Its performance from the start of the year has also been positive, with ALNY up by 32.35% year-to-date.
Alnylam Pharmaceuticals Inc. (ALNY) started the day trading at $149.96 and recorded an intraday high of $154.68. It also recorded an intraday low of $149.37 during Monday’s trading session. Alnylam Pharmaceuticals Inc. is a very active stock that recorded a trading volume that is more than 6.79% of the average daily trading volume on Monday. The stock’s trading volume on Monday was 923597, which is more than 6.79 of the total average daily trading volume of 860.92K.
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) 2020 Performance Impressive
The increase in ALNY’s stock price on Monday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of ALNY currently stands at $158.37, which is higher than the current trading price of the stock by 3.75%. However, ALNY’s current trading price is -120.56% lower than the 52-week low price of $69.11. In terms of trading volume, Alnylam Pharmaceuticals Inc. currently experienced healthy participation during the last trading session. 923597 shares of Alnylam Pharmaceuticals Inc. were traded on the stock exchange on Monday, which is more than 6.79% of the 860.92K average trading volume of the stock.
The performance of the stock has been positive over the past year. ALNY’s performance over the past one year has seen it surge by 111.15%, while the stock has gone up by 31.77% in the last six months. The quarterly performance of ALNY currently stands at 44.05%, and it is up by 15.56% in the last month. The only positive figure was from the weekly performance, which currently reads 0.35%. At the time of writing ALNY’s report, the company has a total market cap of $17.37B, making it one of the largest publicly-traded companies in the world.Alnylam Pharmaceuticals Inc. also has over 1323 employees all over the world.
ALNY Insider Activities
For Alnylam Pharmaceuticals Inc., insiders hold 95.90% of all company shares. The insider transactions over the past six months are up by 2.90%. During that period, insiders bought 366,106 shares in 27 transactions. In that same period, insiders sold 354,964 of their shares in 42 transactions. After these transactions, insiders at Alnylam Pharmaceuticals Inc. now hold 919.7k shares, which is over 94.74% of the total company stocks. Institutional investors currently hold a large chunk of the ALNY shares, as they control 0.80% of the company’s total stock.
ALNY Fundamental Analysis
For Alnylam Pharmaceuticals Inc., the stock’s diluted earnings per share (EPS) stands at -8.03. In the coming year, analysts expect the EPS to be -4.43. The EPS growth will up over the next five years to 46.09% after plunging by -10.80% in the previous five years. In terms of revenue, Alnylam Pharmaceuticals Inc.’s quarterly sales (YOY) is shrinking at -1.48, which is higher than the average annual revenue of -10.80% over the past half a decade.
The Return on Investment (ROI) on Alnylam Pharmaceuticals Inc.’s stock currently stands at -65.40%. The gross margin of the company is 87.80%.
ALNY Analysts Prediction
The JP Morgan has a Neutral rating for Alnylam Pharmaceuticals Inc., predicting the stock price to stay between $133 and $137. and Chardan Capital Markets also reiterate their Buy position on the stock ($150 and $190).
Chardan Capital Markets and BofA/Merrill also believe that Alnylam Pharmaceuticals Inc.’s stock is outperforming at the moment.
ALNY Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of ALNY currently stands at 8.17%, while the SMA50 is 9.23%. The biggest one is the SMA200, which is currently reading 32.09% ahead of Monday’s trading session. The Relative Strength Index of this stock is 61.18.